Nicca Chemical Co., Ltd.TSE: 4463

Summary of Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)

· Issued by Nicca Chemical Co., Ltd.

Translation

Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.



Summary of Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)

Company name: Nicca Chemical Co., Ltd. Stock exchange listing: Tokyo, Nagoya

Stock code: 4463 URL https://www.nicca.co.jp

Representative: President and Representative EMORI Yasumasa Director, Member of the Board

May 1, 2025

Inquiries:

General manager of Administration Division

SAWASAKI Shoya TEL 0776-24-0213

Scheduled date to commence dividend payments: -Preparation of supplementary material on financial results: Yes Holding of financial results meeting: No

(Amounts less than one million yen are rounded down)

  1. Consolidated financial results for the three months ended March 31, 2025 (from January 1, 2025 to March 31, 2025)

    1. Consolidated operating results (cumulative) Percentages indicate year-on-year changes

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Three months ended March 31, 2025

      13,195

      7.9

      856

      45.6

      804

      5.0

      292

      (8.0)

      Three months ended March 31, 2024

      12,228

      6.1

      588

      227.9

      766

      172.6

      318

      -

      Earnings per share

      Diluted earnings per share

      Yen

      Yen

      Three months ended March 31, 2025

      18.50

      -

      Three months ended March 31, 2024

      20.14

      -

    2. Consolidated financial position

      Total assets

      Net assets

      Equity ratio

      Net assets per share

      Millions of yen

      Millions of yen

      %

      Yen

      As of March 31, 2025

      61,083

      34,896

      52.7

      2,031.14

      As of December 31, 2024

      62,366

      36,553

      54.0

      2,125.60

  2. Cash dividends

    Annual dividends per share

    1st quarter-end

    2nd quarter-end

    3rd quarter-end

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Year ended December 31, 2024

    -

    25.00

    -

    27.00

    52.00

    Year ending December 31, 2025

    -

    Year ending December 31, 2025 (Forecast)

    30.00

    -

    30.00

    60.00

  3. Forecast of consolidated financial results for the year ending December 31, 2025 (from January 1, 2025 to December 31, 2025)

    Percentages indicate year-on-year changes

    Net sales

    Operating profit

    Ordinary profit

    Profit attributable to owners of parent

    Earnings per share

    Full year

    Millions of yen

    57,000

    %

    5.4

    Millions of yen

    3,600

    %

    2.3

    Millions of yen

    3,700

    %

    (6.9)

    Millions of yen

    2,600

    %

    (5.6)

    Yen

    164.37

  4. Notes

    1. Significant changes in the scope of consolidation during the three months ended March 31, 2025: No

    2. Application of special accounting methods for preparing quarterly consolidated financial statements: Yes

    3. Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements Changes in accounting policies due to revisions to accounting standards and other regulations: No Changes in accounting policies due to other reasons: No

      Changes in accounting estimates: No

      Restatement of prior period financial statements: No

    4. Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

17,710,000 shares

As of December 31, 2024

17,710,000 shares

As of March 31, 2025



Number of treasury shares at the end of the period

1,879,105 shares

As of December 31, 2024

1,864,105 shares

As of March 31, 2025



Average number of shares during the period (cumulative from the beginning of the fiscal year)

15,805,237 shares

Three months ended March 31, 2024

15,834,645 shares

Three months ended March 31, 2025



Quarterly consolidated financial statements Consolidated balance sheets

Assets

Current assets

(Millions of yen) As of December 31, 2024 As of March 31, 2025

Cash and deposits

10,726

10,424

Notes and accounts receivable - trade, and contract assets

11,996

10,647

Merchandise and finished goods

5,314

5,023

Work in process

818

851

Raw materials and supplies

4,372

4,536

Other

1,005

1,086

Allowance for doubtful accounts

(13)

(12)

Total current assets

34,221

32,556

Non-current assets

Property, plant and equipment

Buildings and structures, net

12,401

11,983

Machinery, equipment and vehicles, net

2,365

2,216

Land

7,760

7,663

Other, net

1,475

2,728

Total property, plant and equipment

24,002

24,591

Intangible assets

Other

510

551

Total intangible assets

510

551

Investments and other assets

Other

3,631

3,383

total Investments and other assets, gross

3,631

3,383

Total non-current assets

28,144

28,526

Total assets

62,366

61,083

Liabilities

Current liabilities

(Millions of yen) As of December 31, 2024 As of March 31, 2025

Notes and accounts payable - trade

6,181

5,571

Short-term borrowings

4,300

6,250

Current portion of long-term borrowings

1,368

1,868

Income taxes payable

534

337

Provision for bonuses

961

413

Provision for bonuses for directors (and other officers)

15

4

Other

3,783

3,718

Total current liabilities

17,143

18,163

Non-current liabilities

Long-term borrowings

4,234

3,642

Retirement benefit liability

3,132

3,090

Provision for share-based payments

210

209

Other

1,091

1,081

Total non-current liabilities

8,668

8,024

Total liabilities

25,812

26,187

Net assets

Shareholders' equity Share capital

2,898

2,898

Capital surplus

2,960

2,960

Retained earnings

24,251

24,117

Treasury shares

(1,407)

(1,394)

Total shareholders' equity

28,703

28,581

Accumulated other comprehensive income

Valuation difference on available-for-sale securities

719

599

Foreign currency translation adjustment

4,119

2,905

Remeasurements of defined benefit plans

107

98

Total accumulated other comprehensive income

4,946

3,603

Non-controlling interests

2,903

2,711

Total net assets

36,553

34,896

Total liabilities and net assets

62,366

61,083

Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative) Consolidated statements of income (cumulative)

(Millions of yen)

Three months ended

March 31, 2024

Three months ended

March 31, 2025

Net sales

12,228

13,195

Cost of sales

7,959

8,413

Gross profit

4,268

4,782

Selling, general and administrative expenses

3,680

3,926

Operating profit

588

856

Non-operating income

Interest income

17

24

Dividend income

1

3

Share of profit of entities accounted for using equity method

5

1

Foreign exchange gains

74

-

Gain on valuation of currency swaps

29

18

Other

63

23

Total non-operating income

192

70

Non-operating expenses

Interest expenses

9

26

Foreign exchange losses

-

73

Other

4

22

Total non-operating expenses

14

122

Ordinary profit

766

804

Extraordinary income

Gain on sale of non-current assets

0

0

Total extraordinary income

0

0

Extraordinary losses

Loss on retirement of non-current assets

0

0

Loss on sale of non-current assets

0

0

Loss on sale of investment securities

0

-

Total extraordinary losses

0

1

Profit before income taxes

766

803

Income taxes

376

425

Profit

390

378

Profit attributable to non-controlling interests

71

85

Profit attributable to owners of parent

318

292

Consolidated statements of comprehensive income (cumulative)

(Millions of yen)

Three months ended

March 31, 2024

Three months ended

March 31, 2025

Profit

390

378

Other comprehensive income

Valuation difference on available-for-sale securities

99

(119)

Foreign currency translation adjustment

779

(1,390)

Remeasurements of defined benefit plans, net of tax

8

(9)

Total other comprehensive income

887

(1,519)

Comprehensive income

1,277

(1,141)

Comprehensive income attributable to

Comprehensive income attributable to owners of parent

1,130

(1,050)

Comprehensive income attributable to non-controlling interests

146 (90)

Company analysis

Earlier from Nicca Chemical

All Nicca Chemical news releases